Susquehanna International Group’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Sell |
12,437
-18,590
| -60% | -$28.4K | ﹤0.01% | 6158 |
|
|
2025
Q1 | $38.2K | Buy |
+31,027
| New | +$38.2K | ﹤0.01% | 6064 |
|
|
2024
Q2 | – | Sell |
-14,817
| Closed | -$63.7K | – | 6254 |
|
|
2024
Q1 | $63.7K | Buy |
+14,817
| New | +$63.7K | ﹤0.01% | 5128 |
|
|
2023
Q2 | – | Sell |
-17,606
| Closed | -$12.5K | – | 6178 |
|
|
2023
Q1 | $12.5K | Buy |
+17,606
| New | +$12.5K | ﹤0.01% | 5693 |
|
|
2022
Q4 | – | Sell |
-1,480
| Closed | -$5K | – | 6428 |
|
|
2022
Q3 | $5K | Buy |
+1,480
| New | +$5K | ﹤0.01% | 5896 |
|
|
2022
Q2 | – | Sell |
-17,154
| Closed | -$76K | – | 6359 |
|
|
2022
Q1 | $76K | Sell |
17,154
-21,026
| -55% | -$93.2K | ﹤0.01% | 5211 |
|
|
2021
Q4 | $363K | Buy |
38,180
+15,242
| +66% | +$145K | ﹤0.01% | 4248 |
|
|
2021
Q3 | $388K | Buy |
22,938
+18,176
| +382% | +$307K | ﹤0.01% | 4012 |
|
|
2021
Q2 | $133K | Buy |
4,762
+419
| +10% | +$11.7K | ﹤0.01% | 4996 |
|
|
2021
Q1 | $97K | Buy |
4,343
+3,250
| +297% | +$72.6K | ﹤0.01% | 4988 |
|
|
2020
Q4 | $16K | Buy |
+1,093
| New | +$16K | ﹤0.01% | 4695 |
|
|
2020
Q3 | – | Sell |
-1,884
| Closed | -$39K | – | 4770 |
|
|
2020
Q2 | $39K | Sell |
1,884
-590
| -24% | -$12.2K | ﹤0.01% | 4061 |
|
|
2020
Q1 | $47K | Sell |
2,474
-3,437
| -58% | -$65.3K | ﹤0.01% | 4229 |
|
|
2019
Q4 | $170K | Buy |
5,911
+598
| +11% | +$17.2K | ﹤0.01% | 3556 |
|
|
2019
Q3 | $271K | Sell |
5,313
-801
| -13% | -$40.9K | ﹤0.01% | 3533 |
|
|
2019
Q2 | $484K | Sell |
6,114
-1,542
| -20% | -$122K | ﹤0.01% | 2962 |
|
|
2019
Q1 | $505K | Buy |
7,656
+5,610
| +274% | +$370K | ﹤0.01% | 1841 |
|
|
2018
Q4 | $114K | Buy |
+2,046
| New | +$114K | ﹤0.01% | 3151 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4186 |
|